CUV 1.61% $14.68 clinuvel pharmaceuticals limited

...so the fda denied a ph iii attempt

  1. 648 Posts.
    Disappointing that the FDA apparently denied Clinuvel's attempt to jump to a Phase III trial in the US, especially given Phase III is over in Europe.

    This will delay a US launch for another year.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.